Annals of Neurology

Article	Citations
	222
Reply to “Urinary α‐Synuclein for Parkinson's Detection: Key Limitations and Future Directions”	180
Issue Information	151
Vertebral Artery Pseudoaneurysm: Novel Marker of Bow Hunter's Syndrome	115
	111
Annals of Neurology: Volume 97, Number 1, January 2025	106
Furthering Female Faculty: An American Neurological Association/Association of University Professors of Neurology Perspective	104
A Letter Concerning a Role for Blood–Brain Barrier Dysfunction in Delirium following Noncardiac Surgery in Older Adults	102
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers	90
The Use of Antihypertensive Medication and In Vivo Alzheimer's Disease Pathology	89
Plasma Metabolites Link Dietary Patterns to Stroke Risk	87
Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic	85
HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis	84
Biological Age Acceleration and Motoric Cognitive Risk Syndrome	80
Staufen Impairs Autophagy in Neurodegeneration	76
Frailty across Neurological Diseases: Why Sex and Gender Matter	74
Carotid Stent Fracture	72
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID‐19 Vaccination	72
Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment	71
Effect of Imaging Markers on Reperfusion Therapy in Basilar Artery Occlusion	68
Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics	67
Cerebrospinal Fluid Flow in Patients with Huntington's Disease	67
Microneurography Reveals Unmyelinated Small Nerve Fiber Dysfunction in Long COVID	65
Blood Pressure after Successful Endovascular Therapy: A Systematic Review and Meta‐Analysis of Randomized Control Trials	64
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis	64

Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS	62
Guanylate Kinase 1 Deficiency: A Novel and Potentially Treatable Mitochondrial DNA Depletion/Deletions Disease	61
Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids: A Potentially Overlooked Diagnosis	61
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein–Barr Virus in MS Development: A Presymptomatic Case–Control Study	60
Diet, Pace of Biological Aging, and Risk of Dementia in the Framingham Heart Study	60
A Managed Care System with Telemedicine Support for Neurological Emergencies	59
A Role for Insulin‐like Growth Factor 1 in the Generation of Epileptic Spasms in a murine model	57
Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function	57
Prevalence of Cerebral Amyloid Angiopathy and Associated Risk of Subsequent Ischemic and Hemorrhagic Stroke and Mortality in a Nationwide Cohort	55
Network Localization of Awareness in Visual and Motor Anosognosia	55
Efficacy and Safety of Ofatumumab Treatment for Anti‐NMDA Receptor Autoimmune Encephalitis (OFF‐AE): A Prospective, Multicenter Cohort Study	55
Annals of Neurology: Volume 99, Number 5, May 2026	55
Cortical Microhemorrhage Presentation of Small Vessel Primary Angiitis of the Central Nervous System	55
Annals of Neurology: Volume 94, Number S30, September 2023	53
Cover Image	53
Issue Information	53
RAN Translation of C9orf72‐Related Dipeptide Repeat Proteins in Zebrafish Recapitulates Hallmarks of Amyotrophic Lateral Sclerosis and Identifies Hypothermia as a Therap	52
Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt	51
Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials	50
Sensorimotor Cortex High Frequency Oscillations Characterize Motor Symptom Severity during Deep Brain Stimulation Surgery for Parkinson's Disease	50
Reply to “ AI: Need for Comparative Studies in Complex Neurologic Diagnosis”	50
Cross‐Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease	49
Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia	48
Clarifying the Moderating Role of Socioeconomic Status on Amyloid‐Related Gray Matter Atrophy	48
Sports Concussion and Category Mistakes	48
GABRA1‐Related Disorders: From Genetic to Functional Pathways	47
MEK Pathway Inhibitor‐Mediated Response in BRAF V600‐Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases	47
APOE2 Exacerbates TDP‐43 Related Toxicity in the Absence of Alzheimer Pathology	47
Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM3P Score	46
Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real‐World Cohort	46
Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study	44
Issue Information	44
Illusions of Self‐Motion during Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Tremor	43
Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy	43
Ultrastructural Axon–Myelin Unit Alterations in Multiple Sclerosis Correlate with Inflammation	41
Correction: Regional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia	41
Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry	41
Correction: GATA1 ‐Mediated Transcriptional Regulation of the γ‐Secretase Activating Protein Increases Aβ Formation in Down Syndrome	41
Micro‐Doses of DNP Preserve Motor and Muscle Function with a Period of Functional Recovery in Amyotrophic Lateral Sclerosis Mice	41
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome	40
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate Endpoints	40
Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia	40
Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease	39
A Combined Panel of Salivary Biomarkers in de novo Parkinson's Disease	39
NINDS Corner: The Helping to End Addiction Long‐Term Initiative and Pain Neurology	38
Choroid Plexus Enlargement Exacerbates White Matter Hyperintensity Growth through Glymphatic Impairment	38
Issue Information	38
GGC Repeat Expansion of RILPL1 is Associated with Oculopharyngodistal Myopathy	38
Bilateral Hearing Loss Caused by Inferior Collicular Infarction	37
Reply to “Clinical Relevance of Genetic Variants in Juvenile Stroke Patients: A Plea for a Precise Classification”	37

	37
Reply to “Chance Bias Arising from TSC2 Mutation Imbalance in the PREVeNT Trial”	37
Reply to “Letter on Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Is Associated with Sertraline Use”	37
Reply to “Is There an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?”	37
	36
Issue Information	36
Trigeminal Trophic Syndrome from Lateral Medullary Stroke	36
High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis	36
Use of FDG ‐ PET in Balamuthia mandrillaris	35
Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study	35
Comment on Clinical, Prognostic, and Longitudinal Functional and Neuropsychological Features of West Nile Virus Neuroinvasive Disease in the United States: A Systematic Review and Meta‐Analysis	35
Uncovering Image‐Driven Subtypes with Distinct Pathology and Clinical Course in Autopsy‐Confirmed Four Repeat Tauopathies	35
Is there an Association between Tuber Involvement of the Fusiform Face Area in Autism Diagnosis?	35
	34
Compensated Hypogonadism Identified in Males with Cluster Headache: A Prospective Case‐Controlled Study	34
Automated Neuroprognostication Via Machine Learning in Neonates with Hypoxic‐Ischemic Encephalopathy	34
Determinants of Infarct Core Growth During Inter‐hospital Transfer for Thrombectomy	34
Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype	34
Signs of Cortical Inflammation in Migraine Measured with Quantitative Magnetic Resonance Imaging: A Registry for Migraine (REFORM) Study	34
Extending the Interpretation of Biomarker Dynamics in SOD1 ‐ ALS Proteomics	33
Neocortical LBD in Women and Episodic Memory Decline in Men: Clarifying Sex Effects	33
Nocturnal Pulse Event Frequency Is Reduced in Multiple System Atrophy	33
Prophylactic Fetal Creatine Supplementation Improves Post‐Asphyxial EEG Recovery and Reduces Seizures in Fetal Sheep: Implications for Hypoxic–Ischemic Encephalopathy	33
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles	33
Histopathological Correlates of Lobar Microbleeds in False‐Positive Cerebral Amyloid Angiopathy Cases	32
Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients	32
Brain Iron Dysregulation in Iron Deficiency Anemia‐Related Restless Leg Syndrome Revealed by Neuron‐Derived Extracellular Vesicles: A Case–Control Study	32
Genome‐Wide Analysis of Structural Variants in Parkinson Disease	32
Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's Disease	32
Letter Concerning Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence	32
Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3	32
Neuroimaging Biomarkers for Friedreich Ataxia: A Cross‐Sectional Analysis of the TRACK‐FA Study	32
Heart Rate Profiles During Exercise and Incident Parkinson's Disease	32
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Is Associated with HLA‐A*3303 and HLA‐DPB1*0501	32
Issue Information	31
In Memoriam: Arthur Knight Asbury, MD (1928–2022)	31
Issue Information	31
Issue Information – TOC	31
Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome	30
	30
ANA Investigates: Atrial Fibrillation after Stroke	30
ANA Podcasts & Webinars: Genetics of Epilepsy	30
Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy	29
Adolescent Headache Due to Congenital Pelvic/Sacral Vascular Malformation	29
Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease	29
Cerebral Small Vessel Disease Progression Increases Risk of Incident Parkinsonism	29
Happy 75th National Institute of Neurological Disorders and Stroke	29
Search Strategies for Alzheimer Protector Genes	29
Reply to “The Role of EEG in Predicting Post‐Stroke Seizures and an Updated Prognostic Model ( SeLECT	29
Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA ‐ DRB1	29
Effect of Cumulative Exposure to Ocrelizumab on Memory B‐Cell Repopulation Dynamics in Multiple Sclerosis	28
Correction: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy	28
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations	28
Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study	28
Extra Movements in Healthy People: Challenging the Definition and Diagnostic Practice of Tic Disorders	28
Correction to “Protective Effects of Socioeconomic Status and Lifestyle on Amyloid‐ and White Matter Hyperintensity‐Related Longitudinal Brain Atrophy and Cognitive Decline”	28
Spoken Language Alterations can Predict Phenoconversion in Isolated Rapid Eye Movement Sleep Behavior Disorder: A Multicenter Study	28
Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions	28
Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study	28
Elevated Risk of Cerebral Arteriovenous Malformation Rupture during Pregnancy and Puerperium	28
Evaluation of Soluble Colony Stimulating Factor 1 Receptor (CSF1R) in Peripheral Blood as a Diagnostic Marker of CSF1R‐Related Disorder (CSF1R‐RD) in a Muri	28
Ultra‐Low Level Somatic Mutations and Structural Variations in Focal Cortical Dysplasia Type II	28
CADASIL Affects Multiple Aspects of Cerebral Small Vessel Function on 7T‐MRI	28
Annals of Neurology: Volume 96, Number 2, August 2024	27
SRPK3 Is Essential for Cognitive and Ocular Development in Humans and Zebrafish, Explaining X‐Linked Intellectual Disability	27
Issue Information	27
Annual Report from the Editor‐in‐Chief (2024)	27
Issue Information	27
Disease Characteristics and Treatments Associated with Outcome in Primary Angiitis of the Central Nervous System —A Multicenter Cohort Study in 163 P	26
NORSE, FIRES, and a Polygenic Trickle of Autoimmunity	26
Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD	26
Annals of Neurology: Volume 95, Number 4, April 2024	26
Brainstem Ischemic Syndrome in NF2‐Related Schwannomatosis	26
Correction to Lyden P, Pryor KE, Coffey CS, et al. Final results of the RHAPSODY trial: a multi‐center, phase 2 trial using a continual reassessment	26
Cinematic Rendering of Extracranial to Intracranial Arterial Bypass	25
AAV9‐ DARS2 Gene Therapy Rescues Phenotype in Leukoencephalopathy with Brainstem and Spinal Cord I	25
Relapses, Comorbidities, and Predictors of Outcome in Anti‐ GABA A Recep	25
Reply to “Genetic Risk, Drug Regimens, and the Limits of Equitable Translation”	25
A Carotid Web with Atherosclerotic Plaque	25
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4‐Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers	25

Trametinib in Adults with Neurofibromatosis Type 1‐Related Symptomatic Plexiform Neurofibromas	25
Internal Carotid Artery Pseudoaneurysm and Unilateral Vocal Cord Paralysis Secondary to Parapharyngeal Space Abscess	25
Risk‐Based EEG Allocation: The Next Step for SeLECT ‐ EEG	25
Social Health and Cognitive Change in Old Age: Role of Brain Reserve	25
“Don't Throw the Baby out with the Bathwater”	24
De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Imp	24
Sex Differences in Trends in Stroke Recurrence and Postrecurrence Mortality 2000–2020: Population‐Based Brain Attack Surveillance in Corpus Christi Project	24
Diagnosing Epilepsy with Normal Interictal EEG Using Dynamic Network Models	24
Inflammation in Cerebral Amyloid Angiopathy‐Related Transient Focal Neurological Episodes	24
	24
Polygenic Resistance to Blood Pressure Treatment and Stroke Risk: Insights from the All of Us Research Program	24
Activated Wake Systems in Narcolepsy Type 1	24
Vessel Wall Imaging of a Carotid Web	23
Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke	23
Limbic Stimulation Drives Mania in STN‐DBS in Parkinson Disease: A Prospective Study	23
Disease Progression in Charcot–Marie–Tooth Disease Related to MPZ Mutations: A Longitudinal Study	23
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine	23
Emerging Management Challenges Posed by Atrial Fibrillation Detected After Stroke	23
Temporal Pattern of Cortical Hypoxia in Multiple Sclerosis and Its Significance on Neuropsychological and Clinical Measures of Disability	23
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Stud	23
Ribbon‐Like Sign in Convexity Subarachnoid Hemorrhage	23
The Age at Onset of LRRK2 p. Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Ori	22
Issue Information	22
Cinematic Rendering of Twig‐Like Middle Cerebral Artery	22
Reply to “Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions”	22
Network Localization of Pediatric Lesion‐Induced Dystonia	22
Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a BMI‐ and Age‐Dependent Manner	22
	22
Fostering Academia‐Industry Partnerships to Facilitate Therapeutic Discoveries in Neurology: The Role of ANA as a Catalyst	22
Annals of Neurology: Volume 92, Number 3, September 2022	22
Blood Lactate as a Prognostic Biomarker for Survival and Weight Loss in Amyotrophic Lateral Sclerosis: An Exploratory–Validation Study	22
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future Directions	22
	22
MuSK‐Myasthenia Gravis and Cancer	22
Reply to “Reassessing the Impact of Endovascular Thrombectomy on Cerebral Edema and Functional Outcomes”	21
Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept	21
Phase 1 Evaluation of Elezanumab (Anti–Repulsive Guidance Molecule A Monoclonal Antibody) in Healthy and Multiple Sclerosis Participants	21
Autosomal Recessive Cerebellar Ataxias: Translating Genes to Therapies	21
	21
Resilience to Endoplasmic Reticulum Stress Mitigates Membrane Hyperexcitability Underlying Late Disease Onset in a Murine Model of SCA6	21
Re‐Emergence of Poliovirus in the United States: Considerations and Implications	21
MOG‐IgG‐Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox Vaccination	21
Myelin Oligodendrocyte Glycoprotein Antibody‐Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions	21
Cognitive Effects of Deep Brain Stimulation in GBA‐Related Parkinson Disease	20
Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral Hemorrhage	20
Networks Underlie Temporal Onset of Dysplasia‐Related Epilepsy: A MELD Study	20
Cluster Headache Genomewide Association Study and Meta‐Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor	20
Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia	20
Longitudinal Alterations of Cerebral Blood Flow in High‐Contact Sports	20
Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study	20
Pathogenic Variants in RNU2‐2 , a Non‐coding Spliceosomal RNA , Cause a Distinctive Developmental and	20
Divergent Causes and Convergent Mechanisms of SUDEP	20
Blood‐Based Proteomics for Adult‐Onset Focal Dystonias	20
Novel Monoclonal Antibody Detects Small Aβ Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media	20
Pragmatic Clinical Trials in Neurology	20
Hyperreflective Foci in the Inner Nuclear Layer: Proof‐of‐Concept for an Optical Coherence Tomography Derived Microglia‐Related Marker in Multiple Sclerosis	20
CSF ‐Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery	20
Association of Mismatch Profiles and Clinical Outcome from Endovascular Therapy in Large Infarct: A Post‐Hoc Analysis of the ANGEL‐ASPECT Trial	19
The Starry Cortex of Aβ‐Related Angiitis	19
Annals of Neurology: Volume 93, Number 4, April 2023	19
Spasticity Predicts Motor Recovery for Patients with Subacute Motor Complete Spinal Cord Injury	19
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET Clocks	19
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy	19
Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo	19
Divergent Associations of Slow‐Wave Sleep versus Rapid Eye Movement Sleep with Plasma Amyloid‐Beta	19
Reply to “Type I IFN Signature in NOTCH1‐Related Leukoencephalopathy”	19
Microglial and Astrocytic Responses in the Human Midcingulate Cortex in Huntington's Disease	19
AI in Neurology: Everything, Everywhere, All at Once Part 3: Surveillance, Synthesis, Simulation, and Systems	19
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART	19
Annals of Neurology: Volume 95, Number 3, March 2024	19
Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study	19
Perimesencephalic Hemorrhage from A Superior Cerebellar Artery Dissection	19
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk	19
Life‐Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy	19
Neuroprotection of Low‐Frequency Repetitive Transcranial Magnetic Stimulation after Ischemic Stroke in Rats	19
Proteomics and the Risk of Incident Embolic and Thrombotic Stroke	18
Characterizing Frontal Lobe Seizure Semiology in Children	18
Inhibition of Bone Morphogenetic Protein Signaling Prevents Tau Pathology in iPSC Derived Neurons and PS19 Mice	18
Longitudinal Retinal Changes in MOGAD	18
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alz	18
Disparate Dementia Risk Factors Are Associated with Cognitive Impairment and Rates of Decline in African Americans	18
Mutations in CLCN6 as a Novel Genetic Cause of Neuronal Ceroid Lipofuscinosis in Patients and a Murine Model	18
Brain Atrophy Associated With Risk Variant rs10191329 Extends Beyond Multiple Sclerosis	18
Myelitis‐Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late‐Onset Neuromyelitis Optica Spectrum Disorders	18
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease	18
Cost‐Effectiveness of Endovascular Thrombectomy in Patients with Large Ischemic Stroke	18
Reply to “Letter to the Editor, Regarding ‘Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in	18
Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial	18
DNase1 RS1053874 Polymorphism is Associated with Early Neurological Recovery through NET Modulation and with Long‐Term Survival in Ischemic Stroke: A Prospective Cohort Study	18
Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers	18
Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3	18
Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology‐Specific	17
The FindMNDBiomarker Program: Protein Changes in Motor Neuron Disease/Amyotrophic Lateral Sclerosis Postmortem Tissue and Biofluids	17
	17
Independent Confirmation	17